|
Cytokinetics, valoración DCF Incorporated (Cytk)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Cytokinetics, Incorporated (CYTK) Bundle
Diseñada para la precisión, nuestra calculadora DCF citocinética lo ayuda a evaluar la valoración de citoquinética, incorporada (CYTK) utilizando datos financieros del mundo real, al tiempo que ofrece una flexibilidad completa para modificar todos los parámetros clave para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55.8 | 70.4 | 94.6 | 7.5 | 18.5 | 21.6 | 25.3 | 29.7 | 34.7 | 40.7 |
| Revenue Growth, % | 0 | 26.15 | 34.3 | -92.04 | 145.34 | 17.1 | 17.1 | 17.1 | 17.1 | 17.1 |
| EBITDA | -86.8 | -176.3 | -329.4 | -456.7 | -493.5 | -21.6 | -25.3 | -29.7 | -34.7 | -40.7 |
| EBITDA, % | -155.45 | -250.39 | -348.25 | -6064.86 | -2671.23 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.8 | 9.6 | 8.4 | 11.9 | 9.5 | 7.7 | 9.0 | 10.5 | 12.3 | 14.4 |
| Depreciation, % | 3.28 | 13.68 | 8.88 | 157.93 | 51.59 | 35.49 | 35.49 | 35.49 | 35.49 | 35.49 |
| EBIT | -88.6 | -186.0 | -337.8 | -468.6 | -503.0 | -21.6 | -25.3 | -29.7 | -34.7 | -40.7 |
| EBIT, % | -158.73 | -264.07 | -357.13 | -6222.79 | -2722.82 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 464.1 | 471.6 | 782.6 | 614.8 | 1,076.0 | 21.6 | 25.3 | 29.7 | 34.7 | 40.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.4 | 51.8 | .1 | 1.3 | 16.7 | 8.2 | 9.6 | 11.2 | 13.1 | 15.4 |
| Account Receivables, % | 7.92 | 73.58 | 0.15541 | 17.04 | 90.13 | 37.76 | 37.76 | 37.76 | 37.76 | 37.76 |
| Inventories | -4.4 | -51.8 | -.1 | .0 | .0 | -3.5 | -4.1 | -4.8 | -5.7 | -6.6 |
| Inventories, % | -7.92 | -73.58 | -0.15541 | 0 | 0 | -16.33 | -16.33 | -16.33 | -16.33 | -16.33 |
| Accounts Payable | 8.1 | 21.1 | 25.6 | 21.5 | 20.4 | 11.7 | 13.8 | 16.1 | 18.9 | 22.1 |
| Accounts Payable, % | 14.42 | 29.94 | 27.08 | 285.62 | 110.26 | 54.29 | 54.29 | 54.29 | 54.29 | 54.29 |
| Capital Expenditure | -11.1 | -48.9 | -11.3 | -1.4 | -3.9 | -6.1 | -7.2 | -8.4 | -9.8 | -11.5 |
| Capital Expenditure, % | -19.8 | -69.39 | -11.98 | -18.8 | -21.14 | -28.22 | -28.22 | -28.22 | -28.22 | -28.22 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -114.3 | -209.4 | -349.6 | -468.6 | -503.0 | -21.6 | -25.3 | -29.7 | -34.7 | -40.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -115.4 | -235.6 | -348.0 | -463.5 | -513.9 | -16.7 | -22.3 | -26.1 | -30.6 | -35.8 |
| WACC, % | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -99.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -36 | |||||||||
| Terminal Value | -523 | |||||||||
| Present Terminal Value | -340 | |||||||||
| Enterprise Value | -439 | |||||||||
| Net Debt | 601 | |||||||||
| Equity Value | -1,040 | |||||||||
| Diluted Shares Outstanding, MM | 112 | |||||||||
| Equity Value Per Share | -9.28 |
What You Will Get
- Real CYTK Financial Data: Pre-filled with Cytokinetics' historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Cytokinetics' intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Clinical Trial Parameters: Adjust essential inputs such as patient enrollment rates, treatment efficacy, and study duration.
- Real-Time Data Analysis: Provides instant insights into trial results, statistical significance, and other key metrics.
- High-Precision Forecasting: Utilizes Cytokinetics' real-world data for accurate projections and outcomes.
- Effortless Scenario Simulation: Easily evaluate various clinical scenarios and their potential impacts on results.
- Efficiency Booster: Streamline the process by avoiding the complexities of building trial models from the ground up.
How It Works
- Step 1: Download the Excel file for Cytokinetics, Incorporated (CYTK).
- Step 2: Review the pre-filled financial data and forecasts specific to Cytokinetics.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the results and apply them to your investment strategies.
Why Choose This Calculator for Cytokinetics, Incorporated (CYTK)?
- Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investment advisors.
- Accurate Data: Cytokinetics’ historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience.
Who Should Use Cytokinetics, Incorporated (CYTK) Products?
- Healthcare Investors: Make informed investment choices with cutting-edge pharmaceutical insights.
- Clinical Researchers: Streamline your research with access to comprehensive data on drug efficacy.
- Pharmaceutical Consultants: Quickly tailor presentations or reports for clients in the biotech sector.
- Biotech Enthusiasts: Enhance your knowledge of drug development processes through real-life case studies.
- Educators and Students: Utilize it as a hands-on resource in life sciences and pharmaceutical courses.
What the Template Contains
- Pre-Filled DCF Model: Cytokinetics’ financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Cytokinetics’ profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.